Electra Therapeutics, Inc.

Electra Therapeutics is a late clinical-stage biopharmaceutical company focused on developing precision medicines for immune-mediated diseases and cancer, targeting signal regulatory proteins (SIRP) to selectively deplete disease-driving cells while preserving normal immune function.